These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 8324747)
21. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
23. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992 [TBL] [Abstract][Full Text] [Related]
24. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Kohler MF; Kerns BJ; Humphrey PA; Marks JR; Bast RC; Berchuck A Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):643-50. PubMed ID: 8469448 [TBL] [Abstract][Full Text] [Related]
25. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974 [TBL] [Abstract][Full Text] [Related]
26. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
27. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer. Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268 [TBL] [Abstract][Full Text] [Related]
28. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037 [TBL] [Abstract][Full Text] [Related]
29. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748 [TBL] [Abstract][Full Text] [Related]
30. p53 alterations in chemically induced hamster cheek-pouch lesions. Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462 [TBL] [Abstract][Full Text] [Related]
31. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Marchetti A; Buttitta F; Merlo G; Diella F; Pellegrini S; Pepe S; Macchiarini P; Chella A; Angeletti CA; Callahan R Cancer Res; 1993 Jun; 53(12):2846-51. PubMed ID: 8389245 [TBL] [Abstract][Full Text] [Related]
32. Overexpression and mutation of p53 in endometrial carcinoma. Kohler MF; Berchuck A; Davidoff AM; Humphrey PA; Dodge RK; Iglehart JD; Soper JT; Clarke-Pearson DL; Bast RC; Marks JR Cancer Res; 1992 Mar; 52(6):1622-7. PubMed ID: 1540970 [TBL] [Abstract][Full Text] [Related]
33. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease. De Benedetti VM; Travis LB; Welsh JA; van Leeuwen FE; Stovall M; Clarke EA; Boice JD; Bennett WP Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):93-8. PubMed ID: 8850268 [TBL] [Abstract][Full Text] [Related]
34. Alterations of p53 are common in early stage prostate cancer. Downing SR; Russell PJ; Jackson P Can J Urol; 2003 Aug; 10(4):1924-33. PubMed ID: 14503938 [TBL] [Abstract][Full Text] [Related]
35. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937 [TBL] [Abstract][Full Text] [Related]
36. A modified yeast assay used on archival samples of localized prostate cancer tissue improves the detection of p53 abnormalities and increases their predictive value. Shi XB; Gandour-Edwards R; Beckett LA; Deitch AD; de Vere White RW BJU Int; 2004 Nov; 94(7):996-1002. PubMed ID: 15541116 [TBL] [Abstract][Full Text] [Related]
37. P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study. Høgdall EV; Kjaer SK; Blaakaer J; Christensen L; Glud E; Vuust J; Høgdall CK Gynecol Oncol; 2006 Jan; 100(1):76-82. PubMed ID: 16183105 [TBL] [Abstract][Full Text] [Related]
38. Point mutation of the p53 gene is an infrequent event in untreated prostate cancer. Kunimi K; Amano T; Uchibayashi T Cancer Detect Prev; 1996; 20(3):218-22. PubMed ID: 8769716 [TBL] [Abstract][Full Text] [Related]
39. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan. Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791 [TBL] [Abstract][Full Text] [Related]
40. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]